p57kip2 nuclear export as a marker of oligodendrocytes differentiation: Towards an innovative phenotyping screening for the identification of myelin repair drugs

Barbara Monti, Monti B
EBioMedicine · 2021 · vol. 66 , pp. 103298 · doi:10.1016/j.ebiom.2021.103298 · PMID:33774331 · PMC8024904
Other OA: gold
📄 Open PDF View on PubMed View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-10-04 ⓘ

The paper identifies p57kip2 nuclear export as a marker of oligodendrocyte differentiation to develop an innovative phenotyping screening method for identifying myelin repair drugs.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

MeSH descriptors

Myelin Sheath Myelin Sheath Pharmaceutical Preparations Pharmaceutical Preparations Active Transport, Cell Nucleus Neurogenesis Oligodendroglia

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-10-18T09:30:06.152893+00:00
pubmed
last seen: 2026-10-08T21:30:31.870046+00:00